Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,062 total articles

Under-the-Radar Recovery: A Tactical Long in UnitedHealth

Under-the-Radar Recovery: A Tactical Long in UnitedHealth

UnitedHealth looks like a classic quiet turnaround: core insurance cash flows steady, Optum services margins stabilizing, and tailwinds from Medicare Advantage enrollment and value-based care. This is a tactical long with defined risk management—entry $560.00, stop $520.00, target $640.00—intended for a long-term horizon (180 trading days).

TD SYNNEX: Buy the Hyve-Led Upside — Trade Idea

TD SYNNEX: Buy the Hyve-Led Upside — Trade Idea

TD SYNNEX looks positioned to reaccelerate revenue quality and margin expansion as Hyve automation deployments move from pilot to scale. I recommend a swing-to-position trade: enter at $120.00, stop at $105.00, target $150.00. Catalyst cadence and improving services mix support upside; execution and macro are the main risks.

Buying the Dip in Hut 8: A Risk-First Trade After a $248M Hit

Buying the Dip in Hut 8: A Risk-First Trade After a $248M Hit

Hut 8 reported a headline $248M loss that cleared out expectations, but investors are betting on asset value recovery, operational leverage and potential upside if Bitcoin miners re-rate. This trade idea lays out an actionable long with entry, stop and target, catalysts to watch, and a frank risk framework.

JBSS: Buy the Family Nut Processor Set for a Re-rating

JBSS: Buy the Family Nut Processor Set for a Re-rating

John B. Sanfilippo & Son (JBSS) is a family-run nut processor trading below $1.0 billion market cap, generating solid free cash flow and mid-teens returns on equity. With EPS up sharply in the latest fiscal quarter, conservative balance sheet metrics, and a share base under 12 million, JBSS is a candidate for a measured long trade to capture a mult…

Booking After the 25-for-1 Split: A Tactical Long With Measured Upside

Booking After the 25-for-1 Split: A Tactical Long With Measured Upside

Booking Holdings completed a 25-for-1 forward split on 04/02/2026 that should amplify retail demand and liquidity. Fundamentals remain solid — high free cash flow, mid-20s P/E, and 2025 revenue and EPS growth — making a disciplined long the preferred trade over the next 45 trading days. Risk is real: macro travel shocks, TSA disruptions, and moment…

Buying Orla Mining After the Pullback: A Growth-Weighted Gold Bet

Buying Orla Mining After the Pullback: A Growth-Weighted Gold Bet

Orla Mining has pulled back from recent highs but fundamentals and the macro gold picture argue for a constructive stance. Recent quarterly beats, steady production, a newly instituted quarterly dividend, and exploration upside make ORLA a compelling long trade over the next 180 trading days. I lay out an entry, stop, targets, catalysts and balance…

CoreWeave Revisited: Why I'm Reiterating a Buy on CRWV

CoreWeave Revisited: Why I'm Reiterating a Buy on CRWV

<p>CoreWeave remains my preferred pure-play bet on GPU infrastructure despite clear execution and balance-sheet risks. The company sits on a multiyear demand wave from generative AI, a massive contracted backlog, and accelerating revenue guidance. That combination justifies a high-risk, high-reward long position with disciplined sizing.</p>

Microsoft's AI Reset: A Tactical Long After the Sell-Off

Microsoft's AI Reset: A Tactical Long After the Sell-Off

Microsoft's shares have been punished as investors price in a multi-year AI infrastructure build and near-term margin pressure. At $369.91, the stock trades at a materially lower multiple than its 2025 peak and offers cash-flow durability, a fortress balance sheet and exposure to cloud/AI secular growth. This trade idea lays out a mid-term (45 trad…

Buy MKKGY: Diversified Pharma & Life-Science Exposure at a Value Entry

Buy MKKGY: Diversified Pharma & Life-Science Exposure at a Value Entry

Merck KGaA (MKKGY) combines a high-quality life-science tools franchise, steady pharma royalties and specialty materials. At $25.44 the stock trades at a reasonable P/E of 18.3 and a market cap of roughly $55.3B, offering a compelling risk/reward for a long trade targeting the $31 52-week high. Technicals show constructive momentum (EMA cross, MACD…

XLG: Reasonable Entry Into Mega-Cap Leadership Despite Clear Risks

XLG: Reasonable Entry Into Mega-Cap Leadership Despite Clear Risks

XLG offers concentrated exposure to the market’s largest, fastest-growing names. Recent earnings momentum among mega-cap technology leaders supports a tactical long exposure, but concentration and macro sensitivity mean risk must be capped. Trade plan: enter $80.00, stop $72.00, target $95.00 for a mid-term trade (45 trading days).

Thales ADR: A Practical Long on Europe’s Defense and Security Rebuild

Thales ADR: A Practical Long on Europe’s Defense and Security Rebuild

THLLY (Thales unsponsored ADR) is trading above its short- and medium-term moving averages with bullish momentum indicators and recent volume that suggests renewed investor interest. With Europe increasing defense budgets, growing demand for public-safety and post-quantum cryptography solutions, and Thales’ exposure across defense, aerospace, and c…